4D Molecular Therapeutics, Inc. (FDMT) NASDAQ

8.39

-0.03(-0.36%)

Updated at September 26 04:00PM

Currency In USD

Valuation

Market Cap300.47M
Enterprise Value175.74M
P/E Ratio-2.39
PEG Ratio0.22
Price/Sales Ratio11,872.95
Price/Book Ratio1.11
Enterprise/Revenue10,234.1
Enterprise/EBITDA-1.52

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-5,943.76
Operating Margin-6,676.55

Management Effectiveness

Return On Assets-0.41
Return On Equity-0.4

Income Statement

Revenue37,000
Revenue/Share0
Gross Profit37,000
EBITDA-187.84M
Net Income-160.87M
Diluted EPS-2.98

Balance Sheet

Total Cash293.23M
Total Cash/Share5.24
Total Debt23.08M
Total Debt/Equity0.05
Current Ratio8.75
Book Value Per Share7.53

Price History

52-Week Change-22.39
52-Week High11.13
52-Week Low2.24
Moving Average 50 Days6.29
Moving Average 200 Days4.83

Statistics

Average Volume1.17M
Shares Outstanding46.7M
% Held by Institutions62.6

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A